D. Bouros

发表

Inhibition and role of let-7d in idiopathic pulmonary fibrosis.

Oliver Eickelberg, Naftali Kaminski, Simon C Watkins, 2010, American journal of respiratory and critical care medicine.

Immune Checkpoint Inhibitor-Related Pneumonitis

D. Bouros, K. Syrigos, G. Gomatou, 2020, Respiration.

An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.

Shandra L. Protzko, D. Lynch, H. Collard, 2013, American journal of respiratory and critical care medicine.

American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management

Takeshi Johkoh, Holger J Schünemann, David A Lynch, 2011 .

Surgery and the respiratory muscles

D. Bouros, D. Georgopoulos, N. Siafakas, 1999, Thorax.

Antisynthetase Syndrome Masquerading as Hypersensitivity Pneumonitis

D. Bouros, P. Sfikakis, V. Tzilas, 2021, Respiration.

Epidemiology of interstitial lung diseases in Greece.

D. Bouros, K. Antoniou, A. Karakatsani, 2009, Respiratory medicine.

Current and future therapeutic approaches in idiopathic pulmonary fibrosis

Demosthenes Bouros, D. Bouros, K. Antoniou, 2005, European Respiratory Journal.

Cell Therapy for Idiopathic Pulmonary Fibrosis: Rationale and Progress to Date

D. Bouros, P. Steiropoulos, T. Karampitsakos, 2020, BioDrugs.

Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis.

V. Aidinis, D. Bouros, D. Margaritis, 2009, American journal of respiratory and critical care medicine.

Apoptosis in lung injury and fibrosis

Demosthenes Bouros, D. Bouros, V. Polychronopoulos, 2008, European Respiratory Journal.

Comparative expression profiling in pulmonary fibrosis suggests a role of hypoxia-inducible factor-1alpha in disease pathogenesis.

Vassilis Aidinis, Aristotelis Chatziioannou, Evangelos Tsiambas, 2007, American journal of respiratory and critical care medicine.

Current classification of idiopathic interstitial pneumonias.

D. Bouros, 2000, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

Th1 cytokine pattern (IL-12 and IL-18) in bronchoalveolar lavage fluid (BALF) before and after treatment with interferon gamma-1b (IFN-gamma-1b) or colchicine in patients with idiopathic pulmonary fibrosis (IPF/UIP).

K. Perisinakis, N. Siafakas, I. Tsiligianni, 2004, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

Investigation of IL-18 and IL-12 in induced sputum of patients with IPF before and after treatment with interferon gamma-1b.

N. Siafakas, D. Bouros, K. Antoniou, 2005, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

Tuberculin sensitivity trends in Hellenic army recruits during the period 1981-91.

N. Siafakas, D. Bouros, M. Moschos, 1995, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Autoimmune Biomarkers, Antibodies, and Immunologic Evaluation of the Patient with Fibrotic Lung Disease.

A. Tzouvelekis, D. Bouros, T. Karampitsakos, 2019, Clinics in chest medicine.

The effect of bronchodilation and spirometry on fractional exhaled nitric oxide (FeNO50), bronchial NO flux (JawNO) and alveolar NO concentration (CANO) in children and young adults

D. Bouros, A. Chatzimichael, T. Karampitsakos, 2018, The Journal of asthma : official journal of the Association for the Care of Asthma.

Infliximab therapy in pulmonary fibrosis associated with collagen vascular disease.

N. Siafakas, D. Bouros, K. Antoniou, 2007, Clinical and experimental rheumatology.

Bronchial carcinoids. A review of 22 cases.

N. Siafakas, D. Bouros, P. Fournel, 1996, Oncology.

Current pharmacological treatment of pulmonary arterial hypertension.

D. Bouros, G. Trakada, P. Steiropoulos, 2008, Current clinical pharmacology.

Epidemiology of interstitial lung diseases and their progressive-fibrosing behaviour in six European countries

Z. Daniil, O. Hilberg, W. Wuyts, 2021, ERJ Open Research.

Clinical experience with antifibrotics in fibrotic hypersensitivity pneumonitis: a 3-year real-life observational study

G. Raghu, A. Tzouvelekis, D. Bouros, 2020, ERJ Open Research.

Common Pathogenic Mechanisms Between Idiopathic Pulmonary Fibrosis and Lung Cancer.

Demosthenes Bouros, A. Tzouvelekis, D. Bouros, 2019, Chest.

Lung cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study in Greece.

Z. Daniil, M. Gaga, A. Tzouvelekis, 2019, Pulmonary pharmacology & therapeutics.

Human pentraxin 2 protein treatment for IPF.

A. Tzouvelekis, D. Bouros, K. Antoniou, 2019, The Lancet. Respiratory medicine.

Combined pulmonary fibrosis and emphysema characteristics in a Greek cohort

Z. Daniil, F. Malli, A. Oikonomou, 2019, ERJ Open Research.

Myelodysplastic syndromes and idiopathic pulmonary fibrosis: a dangerous liaison

P. Revy, C. Boileau, V. Pappa, 2019, Respiratory Research.

Safety and efficacy of nintedanib in idiopathic pulmonary fibrosis: A real-life observational study in Greece.

N. Koulouris, D. Bouros, P. Steiropoulos, 2018, Pulmonary pharmacology & therapeutics.

Longitudinal outcomes of patients enrolled in a phase Ib clinical trial of the adipose‐derived stromal cells‐stromal vascular fraction in idiopathic pulmonary fibrosis

A. Tzouvelekis, D. Bouros, S. Anevlavis, 2018, The clinical respiratory journal.

Nintedanib in Severe Idiopathic Pulmonary Fibrosis: Effectiveness through Compassion

D. Bouros, A. Tzouvelekis, 2018, Respiration.

Safety and efficacy of pirfenidone in severe Idiopathic Pulmonary Fibrosis: A real-world observational study.

N. Koulouris, D. Bouros, P. Steiropoulos, 2017, Pulmonary pharmacology & therapeutics.

Biomarkers in Idiopathic Pulmonary Fibrosis: A RAGE-ing Bull in the Arena.

V. Aidinis, A. Tzouvelekis, D. Bouros, 2017, Annals of the American Thoracic Society.

Diagnostic and prognostic challenges in Idiopathic Pulmonary Fibrosis: A patient's "Q and A" approach.

V. Aidinis, A. Tzouvelekis, D. Bouros, 2017, Pulmonary pharmacology & therapeutics.

Usual interstitial pneumonia pattern in the diagnosis of idiopathic pulmonary fibrosis?

D. Bouros, V. Tzilas, 2016, The Lancet. Respiratory medicine.

Warfarin in idiopathic pulmonary fibrosis: friend or foe, is it a matter of genes and heparin?

S. Loukides, A. Tzouvelekis, D. Bouros, 2013, American journal of respiratory and critical care medicine.

Pulmonary autotaxin expression contributes to the pathogenesis of pulmonary fibrosis.

G. Prestwich, V. Aidinis, A. Karameris, 2012, American journal of respiratory cell and molecular biology.

Pirfenidone for idiopathic pulmonary fibrosis

D. Bouros, 2011, The Lancet.

Terminal diffuse alveolar damage in relation to interstitial pneumonias. An autopsy study.

A. Nicholson, D. Hansell, T. Evans, 2003, American journal of clinical pathology.

Acute interstitial pneumonia.

R. D. du Bois, Demosthenes Bouros, D. Bouros, 2000, The European respiratory journal.

Exercise Testing in Idiopathic Pulmonary Fibrosis: Expanding Our Options

D. Bouros, M. Mura, 2021, Respiration.

Quality of life in patients with active sarcoidosis in Greece.

N. Siafakas, A. Tzouvelekis, D. Bouros, 2006, European journal of internal medicine.

Evaluation of health-related quality-of-life and dyspnea scales in patients with idiopathic pulmonary fibrosis. Correlation with pulmonary function tests.

N. Siafakas, D. Bouros, K. Antoniou, 2005, European journal of internal medicine.

The role of video-assisted thoracoscopic surgery in the treatment of parapneumonic empyema after the failure of fibrinolytics

N. Siafakas, D. Bouros, I. Petrakis, 2001, Surgical Endoscopy And Other Interventional Techniques.

Serologic evaluation in idiopathic interstitial pneumonias

D. Bouros, S. Papiris, K. Kagouridis, 2012, Current opinion in pulmonary medicine.

Q fever pneumonia: appearance on chest radiographs.

A. Gikas, Y. Tselentis, D. Bouros, 1999, Radiology.

Interferon gamma for idiopathic pulmonary fibrosis

D. Bouros, 2009, The Lancet.

Induced Sputum versus Bronchoalveolar Lavage Fluid in the Evaluation of Patients with Idiopathic Pulmonary Fibrosis

N. Siafakas, I. Tsiligianni, D. Bouros, 2005, Respiration.

Genetic predisposition and pathogenetic mechanisms of interstitial lung diseases of unknown origin.

G. Verleden, R. D. du Bois, D. Bouros, 2001, The European respiratory journal. Supplement.

Faster onset of bronchodilation with formoterol than with salmeterol in patients with stable, moderate to severe COPD: results of a randomized, double-blind clinical study.

G. D. Cioppa, N. Siafakas, R. Pistelli, 2002, Canadian respiratory journal.

Pulmonary sarcoidosis: Correlation of expiratory high-resolution CT findings with inspiratory patterns and pulmonary function tests

N. Gourtsoyiannis, P. Prassopoulos, D. Bouros, 2001, Acta radiologica.

Lung function in patients with inflammatory bowel disease.

N. Tzanakis, N. Siafakas, Demosthenes Bouros, 1998, Respiratory medicine.

Small airways function in patients with inflammatory bowel disease.

N. Siafakas, D. Bouros, N. Tzanakis, 1998, American journal of respiratory and critical care medicine.

Clinical features of lung cancer in patients with connective tissue diseases: a 10-year hospital based study.

D. Bouros, M. Vasiljević, D. Pesut, 2008, Respiratory medicine.

Idiopathic interstitial pneumonia or idiopathic interstitial pneumonitis: what's in a name?

A. Tzouvelekis, D. Bouros, U. Costabel, 2019, European Respiratory Journal.

Pulmonary hypertension and lung diseases: a suggestion for revision of the clinical classification

D. Bouros, S. Orfanos, I. Tsangaris, 2010, European Respiratory Journal.

Pulmonary hypertension in patients with interstitial lung disease.

D. Bouros, T. Karampitsakos, W. Fares, 2018, Pulmonary pharmacology & therapeutics.

Toll-like receptors in the pathogenesis of pulmonary fibrosis.

A. Tzouvelekis, D. Bouros, T. Karampitsakos, 2017, European journal of pharmacology.

Formoterol and beclomethasone versus higher dose beclomethasone as maintenance therapy in adult asthma.

N. Siafakas, Demosthenes Bouros, D. Bouros, 1999, The European respiratory journal.

Clearance of technetium-99m-DTPA in pulmonary sarcoidosis.

K. Perisinakis, N. Siafakas, D. Bouros, 2016, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

Cystic lung disease in Birt-Hogg-Dubé syndrome. A case series

D. Bouros, V. Tzilas, A. Tzouvelekis, 2020, Respiratory medicine case reports.

Endoluminal metastases of the tracheobronchial tree : is there any way out?

N. Siafakas, D. Bouros, M. Froudarakis, 2001, Chest.

Serum proinflammatory cytokines and its relationship to clinical parameters in lung cancer patients with reactive thrombocytosis.

K. Perisinakis, Demosthenes Bouros, D. Bouros, 2002, Respiratory medicine.

The varied manifestation of pulmonary artery agenesis in adulthood.

P. Paré, N. Siafakas, D. Bouros, 1995, Chest.

Respiratory muscle strength in hypothyroidism.

N. Siafakas, Demosthenes Bouros, D. Bouros, 1992, Chest.

Pneumothorax as a first manifestation of sarcoidosis.

N. Siafakas, D. Bouros, S. Papiris, 1997, Chest.

Acute fatal amiodarone-induced lung toxicity after CABG surgery

D. Bouros, K. Tsakanika, C. Kotoulas, 2011 .

Increased Long-Term Mortality in Healthcare-Acquired Pneumonia: Another Short-Term Lease on Life?

D. Bouros, I. Pneumatikos, 2009, Respiration.

Pleurodesis: everything flows.

N. Siafakas, Demosthenes Bouros, D. Bouros, 2000, Chest.

Pneumothorax Complicating Fatal Bronchiolitis obliterans Organizing Pneumonia

K. Stefanaki, D. Bouros, D. Kofteridis, 1999, Respiration.

Evaluation of ferritin, interleukin-6, interleukin-8 and tumor necrosis factor alpha in the differentiation of exudates and transudates in pleural effusions.

D. Bouros, G. Eliopoulos, M. Alexandrakis, 1999, Anticancer research.

Evaluation of inflammatory cytokines in malignant and benign pleural effusions.

D. Bouros, G. Eliopoulos, N. Karkavitsas, 2000, Oncology reports.

Massive bilateral pleural effusion as the only first presentation of systemic lupus erythematosus.

D. Bouros, P. Panagou, L. Papandreou, 1992, Respiration; international review of thoracic diseases.

Pleural Effusions in Critically Ill Patients

D. Bouros, I. Pneumatikos, 2008, Respiration.

Diagnostic value of ferritin, haptoglobin, alpha 1-antitrypsin, lactate dehydrogenase and complement factors C3 and C4 in pleural effusion differentiation.

E. Castanas, N. Siafakas, D. Bouros, 1997, Respiratory medicine.

Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions: a prospective, double-blind study.

N. Siafakas, Demosthenes Bouros, D. Bouros, 1997, American journal of respiratory and critical care medicine.

Upregulation of Th1 cytokine profile (IL-12, IL-18) in bronchoalveolar lavage fluid in patients with pulmonary sarcoidosis.

N. Siafakas, I. Tsiligianni, A. Tzouvelekis, 2006, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Utility of fibrinolytic agents for draining intrapleural infections.

N. Siafakas, D. Bouros, S. Schiza, 1999, Seminars in respiratory infections.

Association of TGF-β3 and ANXA11 with pulmonary sarcoidosis in Greek population

D. Bouros, A. Rapti, E. Bouros, 2020, Expert review of respiratory medicine.

Obstructive sleep apnea aggravates glycemic control across the continuum of glucose homeostasis.

E. Maltezos, D. Bouros, P. Steiropoulos, 2010, American journal of respiratory and critical care medicine.

Effect of aminophylline on respiratory muscle strength after upper abdominal surgery: a double blind study.

N. Tzanakis, M. Stathopoulou, N. Siafakas, 1993, Thorax.

Telomeropathy in Chronic Hypersensitivity Pneumonitis

D. Bouros, A. Tzouvelekis, 2019, American journal of respiratory and critical care medicine.

Epidemiological characteristics and outcomes from 187 patients with COVID-19 admitted to 6 reference centers in Greece: an observational study during the first wave of the COVID-19 pandemic.

N. Koulouris, S. Loukides, A. Tzouvelekis, 2021, Advances in respiratory medicine.

Long-term oxygen therapy on the island of Crete, Greece.

N. Tzanakis, N. Siafakas, D. Bouros, 1998, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

Low penetrance of antibiotics in the epithelial lining fluid. Experience from the use of inhaled antibiotics in patients with non CF-bronchiectasis.

D. Bouros, T. Karampitsakos, E. Stavropoulou, 2019, Pulmonary pharmacology & therapeutics.

Ergogenic Value of Oxygen Supplementation in Patients with Idiopathic Pulmonary Fibrosis with Isolated Exertional Oxygen Desaturation

I. Vogiatzis, D. Bouros, 2021, Respiration.

Estrogen Signaling and MicroRNAs in Lung Fibrosis. Sex, Hormones, and Rock Scars

A. Tzouvelekis, D. Bouros, 2019, American journal of respiratory and critical care medicine.

Adult respiratory distress syndrome due to Chlamydia pneumoniae in a young adult.

D. Bouros, P. Panagou, S. Tsipra, 1996, Respiratory medicine.

Respiratory muscle strength in hyperthyroidism before and after treatment.

N. Siafakas, D. Bouros, N. Tzanakis, 1992, The American review of respiratory disease.

Azathioprine for Connective Tissue Disease-Associated Interstitial Lung Disease: In Search for Evidence-Based Medicine

D. Bouros, V. Tzilas, N. Kahn, 2020, Respiration.

Penetration of newer quinolones in the empyema fluid

A. Tsatsakis, C. Simopoulos, D. Bouros, 2004, European Respiratory Journal.

Biomarkers in the Evaluation and Management of Idiopathic Pulmonary Fibrosis.

A. Tzouvelekis, D. Bouros, K. Sakamoto, 2016, Current topics in medicinal chemistry.

Perforin down-regulation and adhesion molecules activation in pulmonary sarcoidosis: an induced sputum and BAL study.

N. Siafakas, I. Tsiligianni, A. Tzouvelekis, 2006, Chest.

Consequences of poor compliance in chronic respiratory diseases.

N. Siafakas, D. Bouros, 1992, The European respiratory journal.

Unilateral pulmonary artery agenesis: a case series.

A. Tzouvelekis, D. Bouros, P. Steiropoulos, 2013, Hippokratia.

Agenesis of the lung.

P. Panagou, D. Bouros, 1990, The European respiratory journal.

Intravenous Immunoglobulin for the Treatment of COVID-19: A Promising Tool

D. Bouros, V. Tzilas, S. Papiris, 2020, Respiration.

Noninvasive Ventilation in Acute Pancreatitis Respiratory Failure: Deus ex Machina?

D. Bouros, I. Pneumatikos, 2006, Respiration.

A 58-Year-Old Woman With Lung Nodules and Chronic Cough.

D. Bouros, V. Tzilas, 2021, Chest.

Management of Patients with Interstitial Lung Disease in the Midst of the COVID-19 Pandemic

G. Raghu, D. Bouros, K. Antoniou, 2020, Respiration.

Endotyping of progressive fibrotic interstitial lung diseases: It is the final destination that matters and not the journey

A. Tzouvelekis, D. Bouros, 2020, EBioMedicine.

Gastroesophageal reflux presented with haemoptysis and carinal erythematous lesion resembling in situ carcinoma.

K. Psathakis, D. Bouros, N. Tzanakis, 1998, Respiratory medicine.

Orthodeoxia and platypnoea after acute organophosphorus poisoning reversed by CPAP: a newly described cause and review of the literature.

A. Tsatsakis, N. Siafakas, D. Bouros, 1995, Respiratory medicine.

Primary non-Hodgkin's lymphoma of the larynx treated only by chemotherapy.

D. Bouros, V. Blatsios, A. Emmanouel, 1990, Chest.

Combined pulmonary fibrosis and emphysema associated with microscopic polyangiitis

A. Oikonomou, A. Tzouvelekis, D. Bouros, 2012, European Respiratory Journal.

Miliary Sarcoidosis following Miliary Tuberculosis

N. Siafakas, D. Bouros, K. Hatzakis, 2000, Respiration.

Role of CD146 in detection of apoptotic circulating endothelial cells in obstructive sleep apnea.

A. Tzouvelekis, D. Bouros, I. Kotsianidis, 2007, American journal of respiratory and critical care medicine.

Metformin in Idiopathic Pulmonary Fibrosis “Seeking the Holy-Grail through Drug-Repositioning”

D. Bouros, V. Tzilas, A. Tzouvelekis, 2018, Respiration.

A 77-Year-Old Woman With Sjogren Syndrome Experiencing Progressive Dyspnea on Exertion and Nonproductive Cough.

D. Bouros, V. Tzilas, A. Tzouvelekis, 2020, Chest.

Severe anaerobic necrotizing pneumonia complicated by pyopneumothorax and anaerobic monoarthritis due to Peptostreptococcus magnus.

D. Bouros, P. Panagou, L. Papandreou, 1991, Respiration; international review of thoracic diseases.

Q fever in the Greek Island of Crete: epidemiologic, clinical, and therapeutic data from 98 cases.

A. Gikas, Y. Tselentis, D. Bouros, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Investigation of Lung Involvement in Connective Tissue Disorders

M. Maniati, R. Borie, D. Bouros, 2015, Respiration.

A 63-Year-Old Woman With Pulmonary Micronodules and Chronic Cough.

D. Bouros, V. Tzilas, A. Tzouvelekis, 2019, Chest.

Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome.

A. Nicholson, T. Colby, R. D. du Bois, 2002, American journal of respiratory and critical care medicine.

The Autotaxin-Lysophosphatidic Acid Axis Promotes Lung Carcinogenesis.

V. Aidinis, J. Chun, N. Xylourgidis, 2018, Cancer research.

Lung fibrosis-associated soluble mediators and bronchoalveolar lavage from idiopathic pulmonary fibrosis patients promote the expression of fibrogenic factors in subepithelial lung myofibroblasts.

George Kolios, Eirini Filidou, D. Bouros, 2017, Pulmonary pharmacology & therapeutics.

Spontaneous pneumothorax. A complication of lung cancer?

D. Bouros, E. Andrianopoulos, 1986, Chest.

Respiratory muscles in endocrinopathies.

N. Siafakas, Demosthenes Bouros, D. Bouros, 1993, Respiratory medicine.

Ventilator-associated Pneumonia or Endotracheal Tube-associated Pneumonia?: An Approach to the Pathogenesis and Preventive Strategies Emphasizing the Importance of Endotracheal Tube

D. Bouros, I. Pneumatikos, C. Dragoumanis, 2009, Anesthesiology.

HRCT findings in the lungs of non-smokers with neurofibromatosis.

P. Prassopoulos, A. Oikonomou, D. Bouros, 2011, European journal of radiology.

Bronchoalveolar lavage findings in a young adult with idiopathic pulmonary haemosiderosis and coeliac disease.

N. Siafakas, D. Bouros, T. Rokkas, 1994, European Respiratory Journal.

Idiopathic pulmonary haemosiderosis and autoimmune hypothyroidism: bronchoalveolar lavage findings after cimetidine treatment.

N. Siafakas, D. Bouros, P. Arseniou, 1995, Respiratory medicine.

Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema. A randomized, double-blind study.

N. Siafakas, Demosthenes Bouros, D. Bouros, 1999, American journal of respiratory and critical care medicine.

Mean Platelet Volume and Platelet Distribution Width in non-diabetic subjects with Obstructive Sleep Apnoea Syndrome: New indices of severity?

E. Maltezos, D. Mikhailidis, D. Bouros, 2012, Platelets.

Intrapleural urokinase in the treatment of complicated parapneumonic pleural effusions and empyema.

N. Tzanakis, N. Siafakas, D. Bouros, 1996, The European respiratory journal.

Parapneumonic effusion and empyema: best therapeutic approach.

M. Plataki, D. Bouros, K. Antoniou, 2001, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

Role of streptokinase in the treatment of acute loculated parapneumonic pleural effusions and empyema.

N. Siafakas, D. Bouros, S. Schiza, 1994, Thorax.

Mean Platelet Volume and Platelet Distribution Width in Patients With Chronic Obstructive Pulmonary Disease

E. Maltezos, D. Bouros, E. Nena, 2013, Angiology.

Fibrinolytics in the treatment of parapneumonic effusions.

N. Siafakas, D. Bouros, S. Schiza, 1999, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

Microsatellite DNA instability in COPD.

D. Spandidos, N. Tzanakis, G. Sourvinos, 1999, Chest.

Vitamin D prevents experimental lung fibrosis and predicts survival in patients with idiopathic pulmonary fibrosis.

V. Aidinis, A. Tzouvelekis, D. Bouros, 2019, Pulmonary pharmacology & therapeutics.

Lung cancer in patients with idiopathic pulmonary fibrosis.

Vasilis Aidinis, Theodoros Karampitsakos, A. Tzouvelekis, 2017, Pulmonary pharmacology & therapeutics.

Respiratory muscle strength during continuous ambulatory peritoneal dialysis (CAPD).

N. Siafakas, D. Bouros, N. Tzanakis, 1995, The European respiratory journal.

Eosinophilic pleural effusion due to gliclazide.

N. Siafakas, D. Bouros, N. Tzanakis, 2000, Respiratory medicine.

Nosocomial lower respiratory tract infections: prevalence and risk factors in 14 Greek hospitals

J. Papadakis, S. Levidiotou, P. Nikolaides, 2004, European Journal of Clinical Microbiology and Infectious Diseases.

Formoterol in the management of chronic obstructive pulmonary disease

A. Tzouvelekis, D. Bouros, P. Steiropoulos, 2008, International journal of chronic obstructive pulmonary disease.

Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis

A. Nicholson, D. Bouros, K. Antoniou, 2006, European Respiratory Journal.

Left ventricular diastolic dysfunction in idiopathic pulmonary fibrosis: a tissue Doppler echocardiographic study

G. Giannakoulas, D. Bouros, C. Papadopoulos, 2008, European Respiratory Journal.

Is There Evidence of Early Vascular Disease in Patients with Obstructive Sleep Apnoea Without Known Comorbidities? Preliminary Findings

G. Tsivgoulis, A. Tzouvelekis, D. Bouros, 2013, The open cardiovascular medicine journal.

Precision medicine in idiopathic pulmonary fibrosis therapy: From translational research to patient-centered care.

V. Aidinis, A. Tzouvelekis, D. Bouros, 2021, Current opinion in pharmacology.

Existing and emerging treatments for idiopathic pulmonary fibrosis

D. Bouros, S. Papiris, L. Kolilekas, 2019, Expert review of respiratory medicine.

Crazy paving pattern as a rare radiological manifestation of peripheral T-cell lymphoma (PTCL) with lung involvement: A case report

K. Syrigos, D. Bouros, G. Gomatou, 2018, Respiratory Medicine Case Reports.

Extracellular matrix remodeling in idiopathic pulmonary fibrosis. It is the ‘bed’ that counts and not ‘the sleepers’

V. Aidinis, D. Bouros, S. Papiris, 2017, Expert review of respiratory medicine.

Diagnostic value of BAL lymphocytosis in patients with indeterminate for usual interstitial pneumonia imaging pattern

A. Wells, D. Bouros, U. Costabel, 2019, European Respiratory Journal.

Microsatellite instability and loss of heterozygosity at chromosomes 9 and 17 in non-small cell lung cancer.

D. Spandidos, J. Vergnon, G. Sourvinos, 1998, Chest.

Clinical patterns and treatment outcome in resected elderly lung cancer patients.

D. Subotic, D. Bouros, J. Stojšić, 2011, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Palpation vs pen method for the measurement of skin tuberculin reaction (Mantoux test).

N. Siafakas, D. Bouros, N Siafakas, 1991, Chest.

A Rare Case of Primary Intrapulmonary Neurilemmoma Diagnosed in a 43-Year-Old Asymptomatic Man with a Well-defined Intrapulmonary Mass

D. Bouros, T. Karampitsakos, C. Triantafillidou, 2018, Front. Oncol..

The role of inexperience in measuring tuberculin skin reaction (Mantoux test) by the pen or palpation technique.

N. Siafakas, D. Bouros, N. Tzanakis, 1992, Respiratory medicine.

Effects of surgery on the function of the respiratory muscles.

N. Siafakas, D. Bouros, I. Mitrouska, 1999, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

Safety and Effectiveness of Mycophenolate Mofetil in Interstitial Lung Diseases: Insights from a Machine Learning Radiographic Model

C. Kalogeropoulou, D. Bouros, A. Kazantzi, 2021, Respiration.

Efficacy and safety of sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: a double-blind, randomised, placebo-controlled, phase 2b trial.

M. Kramer, S. Nathan, A. Wells, 2020, The Lancet. Respiratory medicine.

Mean Platelet Volume as a Surrogate Marker for Platelet Activation in Patients With Idiopathic Pulmonary Fibrosis

D. Mikhailidis, A. Tzouvelekis, D. Bouros, 2016, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Patients with IPF and lung cancer: diagnosis and management.

M. Kreuter, P. Spagnolo, C. Vancheri, 2017, The Lancet. Respiratory medicine.

BOOP presenting with haemoptysis and multiple cavitary nodules.

N. Siafakas, D. Bouros, R. Loire, 1995, The European respiratory journal.

Effectiveness of Tc-99m sestamibi compared to Ga-67 in patients with pulmonary sarcoidosis.

J. Damilakis, D. Bouros, N. Tzanakis, 1997, Clinical nuclear medicine.

Interstitial lung abnormalities: ignotum per ignotius.

A. Tzouvelekis, D. Bouros, K. Antoniou, 2019, The Lancet. Respiratory medicine.

Radiological honeycombing: pitfalls in idiopathic pulmonary fibrosis diagnosis

S. Walsh, D. Bouros, V. Tzilas, 2020, Expert review of respiratory medicine.

Pleural Interleukin-1β in Differentiating Transudates and Exudates: Comparative Analysis with Other Biochemical Parameters

D. Bouros, D. Kyriakou, M. Alexandrakis, 2002, Respiration.